Recombinant Nitrosomonas europaea GMP synthase [glutamine-hydrolyzing] (guaA), partial

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Nitrosomonas europaea GMP Synthase [Glutamine-Hydrolyzing] (guaA), Partial

Recombinant Nitrosomonas europaea GMP synthase [glutamine-hydrolyzing] (guaA), partial, refers to a genetically engineered version of the enzyme GMP synthase from the bacterium Nitrosomonas europaea. This enzyme is crucial in purine metabolism, specifically in the conversion of xanthosine monophosphate (XMP) to guanosine monophosphate (GMP), utilizing glutamine as an amino group donor and ATP for energy .

Enzymatic Function and Mechanism

GMP synthase is an amidotransferase that catalyzes the amination of XMP to form GMP. The reaction involves two main steps: glutamine hydrolysis to produce ammonia, and the subsequent amination of XMP using this ammonia. The enzyme consists of two functional domains: a glutaminase domain responsible for glutamine hydrolysis and a synthetase domain that catalyzes the formation of GMP from XMP .

Key Reaction:

ATP+xanthosine 5’-phosphate+L-glutamine+H2OAMP+diphosphate+GMP+L-glutamate\text{ATP} + \text{xanthosine 5'-phosphate} + \text{L-glutamine} + \text{H}_2\text{O} \rightleftharpoons \text{AMP} + \text{diphosphate} + \text{GMP} + \text{L-glutamate}

Structure and Domains

The enzyme structure typically includes a class I amidotransferase domain for glutamine hydrolysis and an ATP pyrophosphatase domain for GMP synthesis. The amidotransferase domain contains a conserved catalytic triad, often involving cysteine, histidine, and glutamic acid residues, which facilitate the removal of the amide nitrogen from glutamine .

Recombinant Expression and Applications

Recombinant expression of GMP synthase allows for the production of large quantities of the enzyme, which can be used in various biochemical and biotechnological applications. This includes studying enzyme kinetics, understanding nitrogen metabolism in bacteria, and potentially developing new biocatalysts for nucleotide synthesis .

Research Findings and Data

While specific data on the recombinant Nitrosomonas europaea GMP synthase (guaA), partial, might be limited, general research on GMP synthases highlights their importance in purine metabolism and their potential as targets for drug development or metabolic engineering.

Table: Key Features of GMP Synthase

FeatureDescription
Enzyme ClassAmidotransferase (EC 6.3.5.2)
ReactionConverts XMP to GMP using glutamine and ATP
DomainsGlutaminase and synthetase domains
Catalytic TriadTypically involves Cys, His, and Glu residues
ApplicationsBiochemical studies, biotechnology, drug development

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. Please specify your desired tag type for preferential development.
Synonyms
guaA; NE0094; GMP synthase [glutamine-hydrolyzing]; EC 6.3.5.2; GMP synthetase; Glutamine amidotransferase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Nitrosomonas europaea (strain ATCC 19718 / CIP 103999 / KCTC 2705 / NBRC 14298)
Target Names
guaA
Uniprot No.

Target Background

Function

Catalyzes the synthesis of GMP from XMP.

Database Links

KEGG: neu:NE0094

STRING: 228410.NE0094

Q&A

What is Nitrosomonas europaea and why is it significant for biochemical research?

Nitrosomonas europaea is a gram-negative obligate chemolithoautotroph that derives all energy and reductant for growth from the oxidation of ammonia to nitrite, playing a crucial role in the biogeochemical nitrogen cycle through nitrification . Its significance stems from its unique metabolism, complete genome sequence (consisting of a single circular chromosome of 2,812,094 bp with 2,460 protein-encoding genes), and its potential applications in environmental monitoring and bioremediation . N. europaea has well-characterized gene clusters that enable ammonia oxidation and various stress responses, making it an excellent model organism for studying chemolithoautotrophic metabolism .

What is the known function of GMP synthase (guaA) in bacteria similar to N. europaea?

GMP synthase [glutamine-hydrolyzing] (guaA) catalyzes the ATP-dependent conversion of xanthosine 5'-monophosphate (XMP) to guanosine 5'-monophosphate (GMP) using glutamine as an amide donor. While the specific characterization of guaA in N. europaea is not directly addressed in the available research, this enzyme is essential for de novo purine biosynthesis in bacteria. In the context of N. europaea's genome, which contains genes necessary for biosynthesis, CO₂ and NH₃ assimilation , guaA would play a critical role in nucleotide metabolism supporting the organism's growth and stress responses.

How does the genomic context of guaA in N. europaea compare to other bacteria?

The N. europaea genome consists of 2,460 protein-encoding genes averaging 1,011 bp in length, with intergenic regions averaging 117 bp . While specific information about the genomic context of guaA is not provided in the search results, the genome analysis reveals that genes are distributed evenly around the genome, with approximately 47% transcribed from one strand and 53% from the complementary strand . Unlike many heterotrophic bacteria, N. europaea has limited genes for catabolism of organic compounds but contains numerous genes for inorganic ion transporters, reflecting its chemolithoautotrophic lifestyle .

What transformation methods have proven successful for creating recombinant N. europaea strains?

Successful transformation of N. europaea has been achieved using plasmid vectors containing promoter regions from genes of interest. For example, transcriptional fusions with green fluorescent protein (GFP) driven by the promoter regions of mbla (NE2571) in pPRO/mbla4 and clpB (NE2402) in pPRO/clpb7 have been successfully used to transform N. europaea (ATCC 19718) . Additionally, suicide vectors harboring internal fragments of target genes (e.g., norB or norQ) transferred from Escherichia coli to wild-type cells of N. europaea via conjugation have been employed for gene disruption through homologous recombination . These methodologies provide a foundation for creating recombinant N. europaea strains expressing modified guaA.

How can I design an experimental system to study the regulation of guaA expression under different environmental conditions?

Based on successful approaches with other N. europaea genes, researchers could create transcriptional fusions where the guaA promoter drives expression of a reporter gene such as GFP . This system would allow monitoring of guaA expression under various environmental conditions, including different ammonia concentrations, exposure to oxidative stress (e.g., H₂O₂), or presence of xenobiotics like chlorinated compounds. For example, previous work demonstrated that GFP-dependent fluorescence in N. europaea transformed with pPRO/mbla4 increased 3- to 18-fold above control levels in response to increasing chloroform concentrations (7 to 28 μM) and 8- to 10-fold in response to increasing hydrogen peroxide concentrations (2.5-7.5 mM) . A similar approach could reveal conditions that influence guaA expression.

What experimental approaches can determine the role of guaA in N. europaea stress responses?

To investigate guaA's role in stress responses, researchers should consider:

  • Gene disruption: Creating guaA-deficient strains through insertion of suicide vectors via homologous recombination, similar to methods used for norB and norQ genes .

  • Complementation studies: Introducing an intact guaA gene in trans to confirm phenotypic changes are due to guaA disruption .

  • Stress exposure assays: Comparing wild-type and guaA-deficient strains' responses to stressors such as reactive nitrogen species, oxidative stress, or chlorinated compounds .

  • Growth kinetics analysis: Measuring growth parameters (rate, yield) under various stress conditions, as performed with NorB-deficient cells exposed to sodium nitroprusside (SNP) .

  • Metabolite profiling: Analyzing changes in purine nucleotide pools and related metabolites in response to stress.

How can I optimize expression and purification of recombinant N. europaea guaA protein while preserving enzymatic activity?

Based on successful approaches with other N. europaea proteins, consider the following optimization strategy:

Expression System Selection:

  • Evaluate both homologous expression in N. europaea and heterologous expression in E. coli

  • For homologous expression, use promoters known to function in N. europaea, such as those of mbla or clpB genes

  • For heterologous expression, consider using E. coli strains designed for expression of proteins with complex folding requirements

Purification Strategy:

  • Employ affinity tags (His, GST) for initial purification

  • Include stabilizing agents in buffers (glycerol, reducing agents)

  • Consider fusion partners that enhance solubility if initial expression yields insoluble protein

  • Implement multi-step purification using ion exchange and size exclusion chromatography

  • Monitor enzyme activity throughout purification to ensure preservation of function

Activity Preservation:

  • Determine optimal pH and temperature conditions based on N. europaea's natural environment

  • Include necessary cofactors (ATP, Mg²⁺) and substrates (glutamine) in stabilization buffers

  • Test the effect of various storage conditions (temperature, buffer composition) on long-term stability

What are the most effective techniques for creating site-directed mutations in guaA to study structure-function relationships?

For creating precise mutations in N. europaea guaA, consider:

  • In vitro mutagenesis approaches:

    • PCR-based site-directed mutagenesis on cloned guaA gene

    • Gibson Assembly for larger modifications or domain swaps

    • Golden Gate Assembly for multiple mutations in parallel

  • In vivo genome editing:

    • Suicide vector-based homologous recombination, similar to the approach used for norB disruption

    • Counterselection systems to facilitate scarless mutations

    • Adaptation of CRISPR-Cas9 systems (if available for N. europaea)

  • Target selection guidance:

    • Focus on catalytic residues predicted from alignment with characterized GMP synthases

    • Investigate residues potentially involved in ammonia-specific regulation

    • Examine domain interfaces to understand subunit interactions

  • Validation methods:

    • Sequencing to confirm mutations

    • Enzymatic assays to measure changes in catalytic parameters

    • Structural analysis (if possible) to confirm predicted effects

What methods can accurately measure GMP synthase activity in cell extracts of wild-type versus recombinant N. europaea strains?

Table 1: Comparative Methods for GMP Synthase Activity Measurement

MethodPrincipleSensitivityAdvantagesLimitations
HPLC AnalysisDirect measurement of GMP productionModerateDirectly quantifies product, high specificityRequires specialized equipment, time-consuming
Spectrophotometric AssayCoupled reaction measuring NADH oxidationModerateReal-time monitoring, relatively simplePotential interference from other cellular components
Radiometric AssayTracking conversion of labeled substratesHighExcellent sensitivity, works with crude extractsRequires radioactive materials, special handling
Mass SpectrometryDirect measurement of substrates/productsVery HighHighly specific, can measure multiple metabolitesExpensive equipment, complex sample preparation

When comparing wild-type and recombinant strains, ensure consistent:

  • Cell growth conditions (similar to those used for studying NorB-deficient strains )

  • Cell disruption methods

  • Protein quantification for normalization

  • Assay conditions (pH, temperature, substrate concentrations)

  • Inclusion of appropriate controls (heat-inactivated extracts, reactions without key substrates)

How should I interpret changes in guaA expression in relation to N. europaea's unique nitrogen metabolism?

When analyzing guaA expression changes in N. europaea, consider the following interpretative framework:

  • Contextual evaluation: N. europaea's metabolism is centered around ammonia oxidation, with genes necessary for catabolism of ammonia, energy generation, biosynthesis, and CO₂/NH₃ assimilation . Changes in guaA expression should be interpreted within this unique metabolic context.

  • Integration with nitrogen metabolism: Consider whether changes correlate with nitrogen oxidation rates or nitrite accumulation, similar to how norCBQD expression relates to nitrogen oxide metabolism .

  • Stress response correlation: Evaluate whether guaA expression changes coincide with other stress responses, as observed with mbla and clpB genes which respond to chloroform and H₂O₂ exposure .

  • Temporal dynamics: Analyze expression patterns across growth phases, considering N. europaea's relatively slow growth rate as a chemolithoautotroph.

  • Regulatory networks: Explore potential regulatory factors, such as the Fnr transcription factor studied in relation to norCBQD expression , which might influence guaA transcription under different conditions.

What statistical approaches are appropriate for analyzing differences in guaA expression or activity under various experimental conditions?

For robust statistical analysis of guaA data:

  • Experimental design considerations:

    • Use a minimum of 3-5 biological replicates per condition

    • Include technical replicates to account for measurement variability

    • Implement appropriate controls for each condition tested

  • For expression data analysis:

    • For continuous measurements (e.g., fluorescence from GFP reporter fusions ): ANOVA with post-hoc tests for multiple comparisons

    • For time-course experiments: repeated measures ANOVA or mixed-effects models

    • For binary comparisons: t-tests or non-parametric alternatives if normality assumptions are violated

  • Dose-response relationships:

    • For concentration-dependent responses (similar to chloroform response in mbla promoter studies ): regression analysis or EC50 determination

    • Consider both linear and non-linear models to best fit biological responses

  • Data transformation:

    • Log transformation for skewed data

    • Normalization to internal controls for reducing batch effects

  • Visualization approaches:

    • Box plots for showing distribution of responses across conditions

    • Heat maps for multi-parameter experiments

    • Principal component analysis for complex datasets with multiple variables

How can I determine whether observed phenotypic changes in recombinant N. europaea strains are specifically attributable to guaA modifications?

To establish causality between guaA modifications and observed phenotypes:

  • Complementation analysis: Reintroduce wild-type guaA into mutant strains to determine if the original phenotype is restored, similar to the complementation approach used with norCBQD genes .

  • Dose-dependency tests: Create strains with varying levels of guaA expression to establish correlation between expression level and phenotype intensity.

  • Site-directed mutagenesis: Generate specific mutations affecting different aspects of guaA function (e.g., catalytic activity versus protein stability) to pinpoint the molecular basis of phenotypic changes.

  • Off-target effect exclusion: Use genome sequencing or targeted PCR to confirm absence of unintended mutations in other genes.

  • Metabolite supplementation: Test if providing GMP or related metabolites can rescue phenotypic defects, confirming the metabolic basis of the observed changes.

  • Comparative analysis with related genes: Examine whether similar phenotypes occur when related purine biosynthesis genes are modified, to determine pathway-specific versus gene-specific effects.

What approaches can overcome difficulties in creating stable guaA knockout strains in N. europaea?

Creating stable guaA knockouts may be challenging if the gene is essential. Consider these strategies:

  • Conditional knockout systems:

    • Inducible promoter control of guaA expression

    • Temperature-sensitive alleles

    • Antisense RNA approaches to reduce but not eliminate expression

  • Media supplementation:

    • Provide guanine or guanosine in growth media to potentially complement GMP synthase deficiency

    • Optimize ammonia concentrations to reduce metabolic stress on mutants

  • Alternative disruption strategies:

    • Partial gene deletions that maintain some function

    • Point mutations in catalytic residues rather than complete gene removal

    • Insertion of regulatory elements to modulate rather than eliminate expression

  • Technical optimization:

    • Modify transformation protocols based on successful approaches for other genes like norB

    • Optimize selection conditions to allow recovery of slow-growing mutants

    • Use suicide vectors with different antibiotic resistance markers

    • Consider counter-selection techniques for scarless mutations

  • Validation approaches:

    • PCR verification of recombination events similar to confirmation methods used for norB disruption

    • Phenotypic characterization under various growth conditions

    • Genetic stability assessment over multiple generations

How can I troubleshoot inconsistent GFP reporter signals when studying guaA promoter activity in N. europaea?

Based on successful GFP reporter studies in N. europaea , address inconsistent signals by:

  • Construct design optimization:

    • Ensure appropriate promoter fragment length (including all regulatory elements)

    • Optimize ribosome binding site for efficient translation

    • Consider codon optimization of GFP for N. europaea

  • Experimental conditions:

    • Standardize growth conditions (media composition, temperature, oxygen availability)

    • Control for ammonia/nitrite concentrations which may affect cellular metabolism

    • Establish consistent time points for measurements relative to growth phase

  • Signal detection:

    • Optimize excitation/emission parameters for N. europaea autofluorescence minimization

    • Implement appropriate blank controls to account for media fluorescence

    • Consider flow cytometry for single-cell analysis to identify population heterogeneity

  • Validation approaches:

    • Correlate GFP signals with direct mRNA measurements (RT-qPCR)

    • Include known responsive promoters (e.g., mbla, clpB ) as positive controls

    • Test multiple independent transformants to account for position effects

  • Technical considerations:

    • Ensure consistent protein extraction methods if measuring cell lysates

    • Normalize fluorescence to cell density or total protein

    • Account for cellular stress responses that might indirectly affect GFP expression

What strategies can address difficulties in purifying enzymatically active recombinant N. europaea guaA protein?

To enhance purification of active guaA protein:

  • Expression optimization:

    • Test multiple expression systems (N. europaea, E. coli, cell-free)

    • Vary induction conditions (temperature, inducer concentration, duration)

    • Evaluate different fusion tags (His, GST, MBP) for improved solubility

  • Buffer optimization:

    • Include stabilizing agents (glycerol, reducing agents, specific ions)

    • Test pH ranges based on N. europaea's physiological pH preference

    • Add enzyme cofactors (ATP, Mg²⁺) and substrate analogs for stability

  • Purification strategy refinement:

    • Implement gentle extraction methods to preserve native conformation

    • Consider rapid purification protocols to minimize time for denaturation

    • Evaluate on-column refolding if inclusion bodies form

    • Use size exclusion chromatography to isolate properly folded multimers

  • Activity preservation:

    • Determine optimal storage conditions (temperature, buffer composition)

    • Test cryoprotectants for freeze-thaw stability

    • Consider lyophilization with appropriate excipients

    • Evaluate enzyme kinetics throughout purification to identify steps causing activity loss

  • Structural considerations:

    • Analyze protein sequence for potential problematic regions (hydrophobic patches, disordered segments)

    • Consider expressing individual domains separately if full-length protein proves difficult

    • Implement site-directed mutagenesis to enhance stability without affecting catalytic function

How might guaA function in N. europaea relate to the organism's unique stress responses to environmental pollutants?

N. europaea has demonstrated stress responses to chlorinated compounds like chloroform, with genes such as mbla and clpB showing increased expression . Future research could investigate:

  • Whether guaA expression or GMP synthase activity changes in response to environmental pollutants, similar to the 3-18 fold increase in GFP fluorescence observed with the mbla promoter in response to chloroform

  • If guaA plays a role in nucleotide metabolism adjustments during xenobiotic stress, potentially supporting DNA repair mechanisms

  • Whether purine nucleotide availability affects the expression or function of stress response proteins in N. europaea

  • If guaA could serve as an additional "sentinel" gene for biosensor development, complementing the existing mbla and clpB-based biosensors that respond to chloroform and hydrogen peroxide

  • The potential role of guaA in cross-talk between nitrogen metabolism and stress response pathways, considering N. europaea's unique chemolithoautotrophic lifestyle

What insights could comparative analysis of guaA across ammonia-oxidizing bacteria provide about evolutionary adaptations to different ecological niches?

Comparative analysis could explore:

  • Sequence conservation and divergence of guaA among ammonia-oxidizing bacteria compared to heterotrophic bacteria

  • Correlation between guaA sequence variations and ecological parameters (pH, temperature, ammonia concentration) in different niches

  • Regulatory differences in guaA expression that might reflect adaptation to specific environmental conditions

  • Whether horizontal gene transfer has influenced guaA evolution in ammonia-oxidizing bacteria

  • Potential co-evolution of guaA with ammonia oxidation machinery, considering N. europaea's specialized metabolism that derives all energy from ammonia oxidation

How might recombinant N. europaea guaA be utilized in developing new biosensors for environmental monitoring?

Building on the successful development of biosensors using mbla and clpB promoters in N. europaea , recombinant guaA could contribute to biosensor technology by:

  • Providing an additional promoter-reporter system if guaA expression responds to specific environmental conditions or pollutants

  • Serving as a metabolic indicator for nitrogen cycling processes if guaA expression correlates with ammonia oxidation rates

  • Contributing to multi-parameter biosensors that simultaneously monitor different aspects of environmental health

  • Potentially improving existing biosensor sensitivity or specificity through protein engineering of guaA-based sensing elements

  • Enabling detection of compounds that specifically affect purine metabolism but might not trigger general stress responses

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.